Ferquisa laboratories trials with saffron extracts for the treatment of stress, anxiety and depression

Our R & D department is making the last double-blind clinical trials with saffron extracts high purity standard safranal 2%, active ingredient responsible for reducing stress and depressive symptoms whose mechanisms of action are still poorly understood.

The experimental data lead to believe in an imminent product launch, but our department reserves the last recorded data for decision-making product launch.

Studies are also underway in conjunction to know whether the effects are enhanced or mitigated by combining these extracts with other active ingredients which act on the CNS.

The herbal extracts used in all tests are within the law as to its use as a food supplement and not pretending to be a substitute for drug therapy prescription signed.